.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Colorcon
Medtronic
Harvard Business School
US Army
Merck
Accenture
Daiichi Sankyo
Novartis
Citi

Generated: July 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074947

« Back to Dashboard
NDA 074947 describes CLOMIPRAMINE HYDROCHLORIDE, which is a drug marketed by Watson Labs, Mylan, Teva, Sandoz, and Taro, and is included in eight NDAs. It is available from twelve suppliers. Additional details are available on the CLOMIPRAMINE HYDROCHLORIDE profile page.

The generic ingredient in CLOMIPRAMINE HYDROCHLORIDE is clomipramine hydrochloride. There are eight drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.

Summary for NDA: 074947

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for NDA: 074947

Suppliers and Packaging for NDA: 074947

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOMIPRAMINE HYDROCHLORIDE
clomipramine hydrochloride
CAPSULE;ORAL 074947 ANDA Mylan Pharmaceuticals Inc. 0378-3025 0378-3025-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3025-01)
CLOMIPRAMINE HYDROCHLORIDE
clomipramine hydrochloride
CAPSULE;ORAL 074947 ANDA Mylan Pharmaceuticals Inc. 0378-3050 0378-3050-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3050-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength25MG
Approval Date:Apr 30, 1998TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Apr 30, 1998TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength75MG
Approval Date:Apr 30, 1998TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Covington
McKinsey
McKesson
Johnson and Johnson
Fish and Richardson
Fuji
Express Scripts
Deloitte
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot